journal
https://read.qxmd.com/read/38433017/corporate-members
#21
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37964672/management-of-kidney-injury-in-critically-ill-patients-with-earthquake-induced-crush-syndrome-a-case-series-of-18-patients
#22
JOURNAL ARTICLE
Murat Aslan, Deniz Özel Bilgi
UNLABELLED: İNTRODUCTION: It was aimed primarily to analyze the development of acute kidney injury (AKI) and treatment management in critically ill patients who developed rhabdomyolysis due to earthquake-related crush syndrome. METHODS: We evaluated 18 patients with crush syndrome who were admitted to the intensive care unit (ICU) after the great earthquake in February 2023 in Turkey. RESULTS: AKI occurred in 83% (n:15) of these patients after ICU admission (AKI-1; 16...
April 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38168893/corporate-members
#23
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37941164/the-effect-evaluation-of-continuous-nursing-intervention-in-patients-with-type-2-diabetic-retinopathy
#24
RANDOMIZED CONTROLLED TRIAL
Hui Du, Jian-Bo Xiao, Jing Li
INTRODUCTION: To evaluate the application effect of continuous nursing intervention in type 2 diabetic retinopathy (DR). METHODS: Patients with type 2 DR were selected and divided into intervention group and control group by random. The control group received routine nursing intervention, and the intervention group received continuous nursing intervention on the basis of the control group. The clinical effects of the two groups were compared. RESULTS: After 1 and 2 years of intervention, the intervention group compared to the control group...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37853934/clinical-application-of-blood-purification-in-polymyositis-dermatomyositis
#25
JOURNAL ARTICLE
Jieting Jia, Defang Meng, Xuexiang Zhang, Nalin Lai, Beibei Zhou, Hua Wei, Xiaocong Li
INTRODUCTION: We investigated the clinical efficacy and safety of blood purification technology in patients with polymyositis/dermatomyositis. METHODS: In a study of 22 patients, 10 cases received blood purification treatment (5 cases received plasma exchange, 5 cases received plasma HA280 immunoadsorption), and 12 cases served as the control group. A 3-month follow-up was conducted to compare the clinical manifestations and laboratory examination. RESULTS: Symptoms and signs of patients in treatment group were significantly improved, and the hormone usage was lower than the control group...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37731293/serum-immunoglobulin-g-level-reduction-is-a-predictor-of-short-term-improvement-in-patients-with-myasthenia-gravis-undergoing-plasmapheresis
#26
JOURNAL ARTICLE
Shingo Konno, Toshiki Fujioka
OBJECTIVES: The aim of the study was to investigate the serological factors in predicting symptom improvement in myasthenia gravis (MG) patients who underwent plasmapheresis (PP). METHODS: The relationship between symptom improvement and change in immunoglobin G (IgG) and acetylcholine receptor antibody (AchR-Ab) levels in 21 MG patients after PP was analyzed. RESULTS: Patients were divided into two groups: the favorable (n = 11) or unfavorable (n = 10) response groups around the median MG composite improvement rate (50 [29, 56]%) 2 weeks after a PP course...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37704402/association-between-serum-sodium-and-28-day-mortality-in-sepsis-patients-a-secondary-data-analysis-from-three-large-critical-illness-cohorts
#27
MULTICENTER STUDY
Wei Li, Shuwen Li, Jia Yuan, Xianjun Chen, Qimin Chen, Chuan Xiao, Qing Li, Lu Li, Ying Liu, Juan He, Lu Chen, Feng Shen
OBJECTIVE: The present study was designed to explore the association between serum sodium and mortality in patients with sepsis by using a large sample, multicenter MIMIC-IV database. METHODS: We extracted the data of 34 925 sepsis patients from the retrospective cohort mimicIV database. After adjusting the confounders, we explored the independent effects of serum sodium on 28-day mortality. RESULTS: A nonlinear relationship existed between serum sodium and 28-day mortality, of which a negative association was found between serum sodium and 28-day mortality (odds ratio: 0...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37646345/the-role-of-plasmapheresis-in-severe-acute-disseminated-encephalomyelitis-with-clinical-findings-of-transverse-myelitis
#28
JOURNAL ARTICLE
Olivia W Fjellbirkeland, Wladimir M Szpirt, Malene L Børresen
INTRODUCTION: Acute disseminated encephalomyelitis is a rare acute demyelinating disease of the central nervous system (CNS). The pathogenesis remains unclear but is suspected to be autoimmune. High doses of methylprednisolone (HDMP) are currently considered standard of treatment. Plasmapheresis (PE) is typically given in steroid refractory cases. There is currently limited evidence supporting its use in ADEM. MATERIALS AND METHODS: We report a 16-year-old girl with ADEM who improved rapidly after initiating PE...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37583361/a-nephrologist-dream-of-peritoneal-dialysis-catheter-with-zero-migration-a-multicenter-prospective-study
#29
MULTICENTER STUDY
Abdullah K Al-Hwiesh, Ibrahiem Saeed Abdul-Rahman, Jose Carolino Divino-Filho, Mohamed A Nasreldin, Amani A Al-Hwiesh, Nadia Al-Audah, Hatem H Althubaini, Moaz Abdulgalil, Ghassan A Salah, Mohammad Z Al-Baggal, Bassam A Abu-Oun, Nehad Al-Audah, Habib S Al-Ramadan, Kaltham Alfalah, Zahra Almarri, Ayat A Al-Awal
INTRODUCTION: PD catheter tip migration is a common complication and a significant cause of catheter malfunction. In this perspective, we present our experience with a new catheter and a new technique that involves the use of a new triple cuff PD catheter and a low entry site in an attempt to prevent PD catheter migration. METHODS: A total of 503 incident PD patients have been studied in more than one PD center over a period of 5 years. RESULTS: During the 5-year follow up we recorded zero percent catheter migration...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37503708/an-increase-in-fibrinogen-levels-despite-plasma-exchange-in-a-myasthenia-gravis-patient-a-case-report
#30
LETTER
Mohadese Golsorkhi, Sayna Norouzi, Amir Abdipour
No abstract text is available yet for this article.
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37469222/diuretics-or-ultrafiltration-in-the-treatment-of-acute-decompensated-heart-failure-an-updated-systematic-review-and-meta-analysis
#31
JOURNAL ARTICLE
Vasileios Terpos, Stefanos Roumeliotis, Panagiotis I Georgianos, Eleni Papa, Dimitrios G Tsalikakis, Evangelos Papachristou, Vassilios Liakopoulos
INTRODUCTION: Hospitalization for decompensated heart failure is a major public health issue. METHODS: We performed a meta-analysis to summarize and analyze if there is a benefit in using ultrafiltration over diuretics in terms of reducing mortality or hospital readmissions, primarily and identified 10 randomized controlled trials (RCTs) including 941 patients. RESULTS: Compared to diuretics, treatment with ultrafiltration was associated with a significant reduction in heart failure hospitalizations (risk ratio [RR]: 0...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37461148/the-effect-of-double-filtration-plasmapheresis-and-corticosteroids-on-patients-with-anti-dipeptidyl-peptidase-like-protein-6-encephalitis
#32
JOURNAL ARTICLE
Wenbin Wan, Yuanmei Pan, Ying Chen, Shuwei Bai, Xiaoying Yao, Yan Lin, Jun Wu, Liping Ni, Yufang Mei, Huiying Qiu, Yan Zhou, Yong Hao, Yangtai Guan
INTRODUCTION: Anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis is a rare condition with varied symptoms including gastrointestinal issues, weight loss, cognitive and mental dysfunction, and hyperexcitability of the central nervous system. METHODS: We studied five patients with anti-DPPX encephalitis who received immunotherapy, specifically DFPP, at our hospital. We analyzed their clinical symptoms, lab results, electrophysiological and imaging findings, and outcomes with immunotherapy...
February 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38225794/effectiveness-and-safety-of-plasma-exchange-for-anti-mda5-antibody-positive-clinically-amyopathic-dermatomyositis-with-rapidly-progressive-interstitial-lung-disease-refractory-to-intensive-immune-suppression-therapy-a-case-series
#33
JOURNAL ARTICLE
Tomoka Watanabe, Misaki Taniguchi, Sanae Ogura, Mea Asou, Shunsuke Takayanagi, Yuko Sokai, Yoshiki Tsuji, Keita P Mori, Tomomi Endo, Toshiki Nakajima, Yoshitaka Imura, Tatsuo Tsukamoto
INTRODUCTION: Clinically amyopathic dermatomyositis (CADM) with anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab) with rapidly progressive interstitial lung disease (RP-ILD) is often refractory for intensive immunosuppression. In this study, we verified the effectiveness and safety of plasma exchange (PEx) for this lethal disease. METHODS: We retrospectively examined the clinical course and adverse effect (AE) of 12 patients with anti-MDA5 Ab-positive CADM between January 2017 and December 2021 in our hospital...
January 15, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38199237/the-efficacy-and-safety-of-ivabradine-hydrochloride-in-hemodialysis-patients-with-chronic-heart-failure
#34
JOURNAL ARTICLE
Sayuri Kawasaki, Yukinao Sakai, Shinsuke Harasawa, Akihito Inatsu, Yoshiaki Kubota, Akio Hirama, Tetsuya Kashiwagi, Masato Iwabu
INTRODUCTION: There is little evidence for ivabradine hydrochloride in patients undergoing hemodialysis. METHODS: In this open-label prospective interventional trial of hemodialysis patients with chronic heart failure, during 12 weeks of treatment, changes in Heart rate (HR), frequency of dialysis-related hypotension were examined, and we investigated health-related quality of life (HR-QOL) and adverse effects. RESULTS: 18 patients from 6 facilities were enrolled in the study...
January 10, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38173140/meta-analysis-of-regional-citrate-versus-heparin-anticoagulation-for-continuous-renal-replacement-therapy
#35
LETTER
Meint Volbeda, Casper F M Franssen
No abstract text is available yet for this article.
January 3, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38173128/correlation-between-bradykinin-concentration-and-blood-pressure-during-rheocarna-therapy-a-single-center-case-series
#36
JOURNAL ARTICLE
Takaya Handa, Masaki Fujii, Masumi Ando, Mayumi Masuda, Yuko Sokai, Yoshiki Tsuji, Yui Fukuda, Kaoru Ohue, Yoshiaki Higashi, Keita P Mori, Tomomi Endo, Tatsuo Tsukamoto
INTRODUCTION: A novel LDL (low-density lipoprotein) apheresis therapeutic option, Rheocarna, has garnered attention as an alternative therapy for chronic limb-threating ischemia (CLTI). Bradykinin-mediated vasodilation is involved in the effects of LDL apheresis and a decrease in blood pressure (BP), but the changes in bradykinin concentration during Rheocarna therapy are unknown. METHODS: The study involved patients with CLTI treated with Rheocarna at our hospital, from April 2022 to August 2023...
January 3, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38168492/the-clinical-efficacy-and-safety-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-crohn-s-disease-a-multicenter-retrospective-pilot-study
#37
JOURNAL ARTICLE
Nobuhiro Ueno, Seisuke Saito, Masahiro Sato, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Kohjiro Sugimura, Takahiro Sasaki, Aki Sakatani, Keitaro Takahashi, Kazuyuki Tanaka, Shinya Serikawa, Katsuyoshi Ando, Shin Kashima, Momotaro Muto, Yuhei Inaba, Kentaro Moriichi, Hiroki Tanabe, Toshikatsu Okumura, Mikihiro Fujiya
INTRODUCTION: A remission induction therapy of granulocyte and monocyte adsorptive apheresis (GMA) was given to patients with Crohn's disease (CD). However, establishing an appropriate treatment strategy for GMA in patients with CD remains unclear. METHODS: This study evaluated the clinical efficacy and subsequent clinical progression after GMA in patients with CD who underwent GMA in seven independent institutions in Japan from 2010 to 2023. RESULTS: Sixteen patients were enrolled...
January 2, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38163858/using-the-concept-of-food-as-medicine-to-mitigate-inflammation-in-patients-undergoing-peritoneal-dialysis
#38
REVIEW
Livia Alvarenga, Drielly C M V Reis, Julie Ann Kemp, Karla Thais Resende Teixeira, Denis Fouque, Denise Mafra
The most common kidney replacement therapy (KRT) worldwide is hemodialysis (HD), and only 5%-10% of patients are prescribed peritoneal dialysis (PD) as KRT. Despite PD being a different method, these patients also present particular complications, such as oxidative stress, gut dysbiosis, premature aging, and mitochondrial dysfunction, leading to an inflammation process and high cardiovascular mortality risk. Although recent studies have reported nutritional strategies in patients undergoing HD with attempts to mitigate these complications, more information must be needed for PD patients...
January 1, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38163856/health-literacy-in-older-adults-receiving-hemodialysis-in-turkey-a-cross-sectional-study
#39
JOURNAL ARTICLE
Ziyafet Uğurlu, Sultan Kav, Çiğdem Özdemir Eler, Semiha Kaya, Yasemin Korkmaz
INTRODUCTION: This study aimed to determine the health literacy level and related factors of older adults receiving hemodialysis treatment. METHODS: A cross-sectional study was conducted at the five dialysis centers, using the information form and Turkish Health Literacy Survey-32 (THLS-32). A total of 336 older adults receiving hemodialysis treatment participated. RESULTS: The general health literacy score was found to be 25.69 ± 14...
January 1, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38115783/peritoneal-dialysis-in-herzegovina-federation-of-bosnia-and-herzegovina-18%C3%A2-years-of-experience-from-our-center
#40
JOURNAL ARTICLE
Fila Raguž, Monika Tomić, Andrea Stojčić, Manuel Tipurić, Mile Volarić, Sanja Bevanda
INTRODUCTION: Due to treatment of end-stage-renal-disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD-associated infections. METHODS: Clinical data on 71 patients with CAPD were evaluated in addition to exit site infections and episodes of acute peritonitis (AP). RESULTS: There were 39 men and 32 women. Average age was 61 years when we began CAPD and average time spent on CAPD program was 3...
December 20, 2023: Therapeutic Apheresis and Dialysis
journal
journal
40470
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.